Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FY18W
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,728
Award facts
- Contract value 100% obligated
- $5,728.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,728.47 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contract carries no subcontractor involvement and represents one of numerous delivery orders DMS Pharmaceutical Group has received from the Defense Logistics Agency's Medical Supply Chain division during the October 2025 procurement period.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The parent IDC, awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. Through this vehicle, DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier for Department of Defense healthcare operations worldwide, authorized to deliver a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DB26FY18W?
SPE2DB26FY18W was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FY18W worth?
The government has obligated $5,728 on SPE2DB26FY18W.
Is contract SPE2DB26FY18W an order under another contract?
Yes. SPE2DB26FY18W is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB26FY18W competed?
The extent of competition for SPE2DB26FY18W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award